Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Alpine Immune Sciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- −3 vs. Q4 2022
- Shares held
- 41.4M
- +454.1K (+1.1%) vs. Q4 2022
- Total value
- $319.4M
- +$18.6M (+6.2%) vs. Q4 2022
- New holders
- 5
- 26 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $51.8M | 20.89% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,688,115 | $36.2M | 0.82% | +290,747+6.6% | Added |
| OrbiMed Advisors LLC | 4,081,592 | $31.5M | 0.62% | 00.0% | Unchanged |
| Great Point Partners LLC | 3,740,761 | $28.9M | 5.71% | +103,043+2.8% | Added |
| Lynx1 Capital Management LP | 3,136,173 | $24.2M | 20.18% | +10,000+0.3% | Added |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $23.1M | 1.67% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 2,317,634 | $17.9M | 1.70% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,029,580 | $15.7M | 10.22% | 00.0% | Unchanged |
| BlackRock Inc. | 1,552,920 | $12.0M | 0.00% | +116,060+8.1% | Added |
| Vanguard Group Inc | 1,369,709 | $10.6M | 0.00% | +9,206+0.7% | Added |
| Commodore Capital LP | 1,325,000 | $10.2M | 1.56% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,202,000 | $9.28M | 1.34% | −23,000−1.9% | Reduced |
| Artal Group S.A. | 1,193,030 | $9.21M | 0.55% | 00.0% | Unchanged |
| Avidity Partners Management LP | 989,500 | $7.64M | 0.25% | −38,700−3.8% | Reduced |
| BVF Inc | 858,339 | $6.63M | 0.24% | −277,601−24.4% | Reduced |
| Geode Capital Management, LLC | 556,207 | $4.29M | 0.00% | +70,457+14.5% | Added |
| State Street Corp | 346,671 | $2.68M | 0.00% | +43,253+14.3% | Added |
| Renaissance Technologies LLC | 330,294 | $2.55M | 0.00% | −2,600−0.8% | Reduced |
| TCG Crossover Management, LLC | 253,069 | $1.95M | 0.38% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 247,891 | $1.91M | 0.74% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 200,000 | $1.54M | 0.33% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 200,000 | $1.54M | 0.58% | +200,000 | New |
| Northern Trust Corp | 193,987 | $1.50M | 0.00% | +2,415+1.3% | Added |
| Dimensional Fund Advisors LP | 139,672 | $1.08M | 0.00% | +40,865+41.4% | Added |
| HighVista Strategies LLC | 90,287 | $697.0K | 0.57% | +90,287 | New |
| Bank of New York Mellon Corp | 71,806 | $554.3K | 0.00% | −11,785−14.1% | Reduced |
| Charles Schwab Investment Management Inc | 67,266 | $519.3K | 0.00% | +2,770+4.3% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 54,237 | $418.7K | 0.00% | −4,071−7.0% | Reduced |
| JPMorgan Chase & Co | 48,149 | $372.0K | 0.00% | +33,919+238.4% | Added |
| Two Sigma Advisers, LP | 40,975 | $316.3K | 0.00% | −24,200−37.1% | Reduced |
| Walleye Capital LLC | 34,117 | $263.4K | 0.01% | +34,117 | New |
| Rhumbline Advisers | 32,848 | $254.0K | 0.00% | +6,615+25.2% | Added |
| Nuveen Asset Management, LLC | 31,729 | $245.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 30,857 | $238.2K | 0.00% | +368+1.2% | Added |
| Morgan Stanley | 27,914 | $215.5K | 0.00% | +10,353+59.0% | Added |
| Bank of America Corp | 23,500 | $181.4K | 0.00% | −166−0.7% | Reduced |
| BNP Paribas Arbitrage, SA | 20,518 | $158.4K | 0.00% | +5,007+32.3% | Added |
| Price T Rowe Associates Inc | 19,625 | $152.0K | 0.00% | +224+1.2% | Added |
| Deutsche Bank AG | 14,751 | $113.9K | 0.00% | +6,596+80.9% | Added |
| Hikari Power Ltd | 12,445 | $96.0K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 12,079 | $93.3K | 0.00% | +5,999+98.7% | Added |
| MetLife Investment Management | 12,028 | $92.9K | 0.00% | 00.0% | Unchanged |
| Western Wealth Management, LLC | 12,000 | $92.6K | 0.01% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 11,927 | $92.0K | 0.00% | +11,927 | New |
| American International Group, Inc. | 11,418 | $88.1K | 0.00% | +708+6.6% | Added |
| Susquehanna International Group, LLP | 10,634 | $82.1K | 0.00% | −11,528−52.0% | Reduced |
| California State Teachers Retirement System | 8,796 | $67.9K | 0.00% | −242−2.7% | Reduced |
| UBS Group AG | 7,993 | $61.7K | 0.00% | +5,717+251.2% | Added |
| New York State Common Retirement Fund | 5,505 | $42.5K | 0.00% | +68+1.3% | Added |
| Wells Fargo & Company | 4,392 | $33.9K | 0.00% | +4,392 | New |
| Amalgamated Bank | 2,833 | $22.0K | 0.00% | +448+18.8% | Added |
| Legal & General Group Plc | 2,473 | $19.1K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,900 | $14.7K | 0.00% | +989+108.6% | Added |
| Tower Research Capital LLC (TRC) | 1,499 | $12.0K | 0.00% | +478+46.8% | Added |
| Royal Bank of Canada | 1,327 | $10.0K | 0.00% | −1,828−57.9% | Reduced |
| FMR LLC | 1,256 | $9.70K | 0.00% | +576+84.7% | Added |
| China Universal Asset Management Co., Ltd. | 623 | $4.81K | 0.00% | +156+33.4% | Added |
| Metropolitan Life Insurance Co | 537 | $4.15K | 0.00% | −881−62.1% | Reduced |
| Citigroup Inc | 523 | $4.04K | 0.00% | −71−12.0% | Reduced |
| Daiwa Securities Group Inc. | 85 | $1.00K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 12 | $0 | 0.00% | 00.0% | Unchanged |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −181,886−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −30,924−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,204−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −16,763−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −4,453−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,714−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |